The Galien Basis appoints Michael Rosenblatt, MD, as Chairman of the Prix Galien USA Awards Committee

NEW YORK, Jan 5, 2023 /PRNewswire/ — The Galien Basis right this moment introduced the appointment of Michael RosenblattMD, as Chairman of the Prix Galien USA Awards Committee, composed of prime biomedical scientists, together with Nobel laureates in medication, devoted to the pursuit and recognition of medical analysis to enhance the state of human well being. dr Michael Rosenblatta member of the Galien Awards Committee since 2012, is presently an advisor to biopharma, enterprise, and academia and is the previous Chief Medical Officer of Merck & Co., Inc. and Flagship Pioneering.

His appointment is efficient instantly, succeeding the present Committee Chair, Dr. Susan Desmond-Hellman, former CEO of the Invoice & Melinda Gates Basis, who will proceed as a committee member below Dr. Rosenblatt’s management.

“Following the illustrious management of each P. Roy Vagelos after which Susan Desmond-Hellman on this function, I’m deeply honored to function the subsequent Chairman of the Prix Galien USA Committee. The Prix Galien acknowledges the groups within the biopharmaceutical business which have created a very powerful improvements that enhance well being and tackle unmet medical wants. The Prix Galien is taken into account the ‘Nobel Prize of the biopharmaceutical business’. Constructed on an unequalled community of prime biomedical scientists, together with Nobel Laureates in medication, the Prix Galien is an unbiased program to acknowledge ‘one of the best of one of the best’ in new medicines and diagnostics,” mentioned Dr. Rosenblatt after his choice by Awards Committee colleagues .

“I’ve served on the awards choice committee, which consists of scientific and medical leaders from academia, and the pharmaceutical and biotech sectors, for over a decade. I’m most keen about taking up new tasks to advance the mission of The Galien Basis .I sit up for October 26, 2023after we announce the subsequent group of Prix Galien USA awardees and rejoice their achievements.”

In an announcement, outgoing Chair Dr. Desmond-Hellmann cited Dr. Rosenblatt’s exceptional background on the entrance line of nearly each well being problem of the previous three a long time. “I additionally take nice pleasure within the Committee’s alternative as a result of nobody understands in addition to Mike that the medicines provide chain’s hardest problem is masking that final mile to the affected person. Information of entry platforms and logistics should go hand in hand with nice analysis if the Improvements cited by The Galien Basis are to have sensible affect in the actual world of unmet medical want. Mike will preserve us targeted not simply on recognition, however on outcomes that matter for sufferers too.”

Along with his place as Chairman of the Prix Galien USA Awards Committee, Dr. Rosenblatt serves on the boards of private and non-private biopharmaceutical firms, is a senior advisor to enterprise funds, and is a member of the scientific advisory committees of a number of educational establishments.

Present Members of the Prix Galien USA Committee (2023):

Pr Linda BUCK, Ph.D. Nobel Laureate, Fred Hutchinson Most cancers Analysis Heart Professor, and Affiliate Professor of Physiology and Biophysics, College of Washington
Pr Sue DESMOND-HELLMANN, MD, MPH Former Chief Government Officer of the Invoice & Melinda Gates Basis, SeattleWA
Pr Laurie GLIMCHER, MD CEO and President, Dana Farber Most cancers Institute, Professor of Medication, Harvard Medical College
Pr Mary-Claire KING, Ph.D. American Most cancers Society Professor of Genome Sciences and Medical Genetics, College of Washington
Pr Robert S. LANGER, MD David H. Koch Institute Professor, WITH
Pr Cato T. LAURENCIN, MD, Ph.D. faculty professor, College of Connecticut
dr Steven J. LESTER, MD Chief Medical Officer of the Mayo Clinic-ASU MedTech Accelerator & Professor of Medication, Mayo Clinic School of Medication and Science
Pr Phillip A. SHARP, Ph.D. Nobel Laureate, Professor of Biology and member of the Koch Institute, Chair of the advisory board of the MIT Jameel Clinic
Pr Marc TESSIER-LAVIGNE, Ph.D. president Stanford College, Stanford, CA

Earlier Members of the Prix Galien USA Committee since 2007:

Pr Richard AXEL, MD Nobel Laureate, Co-director, Kavli Institute for Mind Science, Columbia College Medical heart
Pr Michael S BROWNMD Nobel Laureate, UT Southwestern Medical Heart at Dallas
Pr Barry S. COLLER, MD Rockefeller College
Pr Joseph GOLDSTEIN, MD Nobel Laureate, UT Southwestern Medical Heart at Dallas
Pr Paul GREENGARD, PhD Nobel Laureate, Rockefeller College
Pr Eric R. KANDEL, MD Nobel Laureate, Columbia College
Pr Joshua LEDERBERG, MD, PhD Nobel Laureate, Rockefeller College
Pr Richard A.LERNER, MD Scripps Analysis Institute
Pr Paul A. MARKS. md Memorial Sloan Kettering Most cancers Heart
Pr Bengt SAMUELSSON MD PhD Nobel Laureate, Nobel Basis, Karolinska Institute
Pr P. Roy VAGELOS, MD Retired Chairman and CEO, Merck & Co., Inc. Chairman of the Board, Regeneron Prescription drugs, Inc.
Pr Jan T. VILCEK, MD New York College College of Medication
Pr Gerald WEISSMAN, MD New York College College of Medication
Dr. Tachi YAMADA, MD Enterprise Companions, Frazier Healthcare Companions, In Memoriam

About The Galien Basis

The Galien Basis, based by Honorary President Emeritus, Eli Wiesel, human rights activist, acclaimed creator and Nobel Peace Prize Laureate, fosters, acknowledges and rewards excellence in scientific innovation to enhance the state of human well being. Our imaginative and prescient is to be the catalyst for the event of the subsequent era of modern remedies and applied sciences that may affect the state of medical apply and save lives.

The Basis oversees and directs actions within the US for the Prix Galien, a global awards program devoted to progress by modern medicines improvement, with chapters in 14 international locations and Africa. The Prix Galien was created in 1970 by Roland Mehl in honor of Galien, the daddy of medical science and fashionable pharmacology. Worldwide, the Prix Galien is considered the equal of the Nobel Prize in biopharmaceutical analysis.

For extra data, go to

Observe the Basis on social media:

Media Contact:
Kara Bradley
Finn Companions
[email protected]

SOURCE The Galien Basis


Leave a Comment